Bergstrom JP, Helander A. Clinical characteristics of carbohydrate-deficient transferrin (% disialotransferrin) measured by HPLC: sensitivity, specificity, gender effects, and relationship with other alcohol biomarkers. Alcohol Alcohol. 2008;43(4):436–41.
Bhatt DL, Scheiman J, Abraham NS. ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use. Circulation. 2008;118.
Bilbao-Garay J, Barba R, Losa-Garcia JE et al. Assessing clinical probability of organic disease in patients with involuntary weight loss: a simple score. Eur J Intern Med. 2002;13:240–5.
Bradley KA, Boyd-Wickizer J, Powell SH, Burman ML. Alcohol screening questionnaires in women: a critical review. JAMA. 1998;280(2):166–71.
Brent GA. Clinical practice. Graves' disease. N Engl J Med. 2008;358(24):2594–605.
Callery MP, Freedman SD. A 21-year-old man with chronic pancreatitis. JAMA. 2008;299(13):1588–94.
Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101(4):848–63.
Gisbert JP, de la Morena F, Abraira V. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101(8):1921–30.
Hadithi M, von Blomberg BM, Crusius JB et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med. 2007;147(5): 294–302.
Hernandez JL, Riancho JA, Matorras P, Gonzalez-Macias J. Clinical evaluation for cancer in patients with involuntary weight loss without specific symptoms. Am J Med. 2003;114(8):631–7.
, Cross SS, Hurlstone DP et al. Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ. 2007;334(7596):729.
Metalidis C, Knockaert DC, Bobbaers H, Vanderschueren S. Involuntary weight loss. Does a negative baseline evaluation provide adequate reassurance? Eur J Intern Med. 2008;19(5):345–9.
Nakao H, Konishi H, Mitsufuji S et al. Comparison of clinical features and patient background in functional dyspepsia and peptic ulcer. Dig Dis Sci. 2007;52(9):2152–8.
Pignone MP, Gaynes BN, Rushton JL et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136(10):765–76.
Reese GE, Constantinides VA, Simillis C et al. Diagnostic precision of anti- Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol. 2006; 101(10):2410–22.
Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med. 2005;352(6): 596–607.
Schoepfer AM, Trummler M, Seeholzer P, Seibold-Schmid B, Seibold F. Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm Bowel Dis. 2008; 14(1):32–9.
Talley NJ, American Gastroenterological A. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology. 2005;129(5):1753–5.
Triester SL, Leighton JA, Leontiadis GI et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn's disease. Am J Gastroenterol. 2006;101(5): 954–64.
US Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med. 2004;140(7):554–6.